124 related articles for article (PubMed ID: 27220723)
21. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.
Li C; Yang X; Luo Y; Liu H; Zhong X; Zhou X; Zeng T; Tao L; Zhou Y; Gou K; Yang X; Liu X; Chen Q; Zhao Y; Luo Y
J Med Chem; 2021 Dec; 64(24):18175-18192. PubMed ID: 34905371
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarylpyrazole derivatives possessing arylamides or arylureas moieties.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2016 Aug; 119():122-31. PubMed ID: 27155467
[TBL] [Abstract][Full Text] [Related]
24. Discovery and Optimization of Novel
Zhou X; Gou K; Xu J; Jian L; Luo Y; Li C; Guan X; Qiu J; Zou J; Zhang Y; Zhong X; Zeng T; Zhou Y; Xiao Y; Yang X; Chen W; Gao P; Liu C; Zhou Y; Tao L; Liu X; Cen X; Chen Q; Sun Q; Luo Y; Zhao Y
J Med Chem; 2023 Nov; 66(21):14755-14786. PubMed ID: 37870434
[TBL] [Abstract][Full Text] [Related]
25. [Design, synthesis and structure-activity relationship studies of human dihydroorotate dehydrogenase inhibitors].
Gong YH; Liu L; Qi TT; Li HL; Zhu LL; Zhao ZJ
Yao Xue Xue Bao; 2017 Feb; 52(2):264-70. PubMed ID: 29979514
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
Boa AN; Canavan SP; Hirst PR; Ramsey C; Stead AM; McConkey GA
Bioorg Med Chem; 2005 Mar; 13(6):1945-67. PubMed ID: 15727850
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies.
Pippione AC; Sainas S; Goyal P; Fritzson I; Cassiano GC; Giraudo A; Giorgis M; Tavella TA; Bagnati R; Rolando B; Caing-Carlsson R; Costa FTM; Andrade CH; Al-Karadaghi S; Boschi D; Friemann R; Lolli ML
Eur J Med Chem; 2019 Feb; 163():266-280. PubMed ID: 30529545
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and acrosin inhibitory activities of 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives.
Tian W; Han G; Zhu J; Qi J; Chen Q; Zhao J; Zheng C; Zhang L; Zhou Y; Lv J
Bioorg Med Chem Lett; 2013 Jul; 23(14):4177-84. PubMed ID: 23746472
[TBL] [Abstract][Full Text] [Related]
29. Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening.
Diao Y; Lu W; Jin H; Zhu J; Han L; Xu M; Gao R; Shen X; Zhao Z; Liu X; Xu Y; Huang J; Li H
J Med Chem; 2012 Oct; 55(19):8341-9. PubMed ID: 22984987
[TBL] [Abstract][Full Text] [Related]
30. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.
Davis JP; Cain GA; Pitts WJ; Magolda RL; Copeland RA
Biochemistry; 1996 Jan; 35(4):1270-3. PubMed ID: 8573583
[TBL] [Abstract][Full Text] [Related]
31. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy.
Lolli ML; Sainas S; Pippione AC; Giorgis M; Boschi D; Dosio F
Recent Pat Anticancer Drug Discov; 2018; 13(1):86-105. PubMed ID: 29119937
[TBL] [Abstract][Full Text] [Related]
32. Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).
Lucas-Hourani M; Munier-Lehmann H; El Mazouni F; Malmquist NA; Harpon J; Coutant EP; Guillou S; Helynck O; Noel A; Scherf A; Phillips MA; Tangy F; Vidalain PO; Janin YL
J Med Chem; 2015 Jul; 58(14):5579-98. PubMed ID: 26079043
[TBL] [Abstract][Full Text] [Related]
33. Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
Zhang L; Zhang J; Wang J; Ren C; Tang P; Ouyang L; Wang Y
Eur J Med Chem; 2022 Mar; 232():114176. PubMed ID: 35151222
[TBL] [Abstract][Full Text] [Related]
34. N-phenyl ureidobenzenesulfonates, a novel class of promising human dihydroorotate dehydrogenase inhibitors.
Bouzriba C; Larcher L; Gagné-Boulet M; Fortin S
Bioorg Med Chem; 2020 Nov; 28(22):115739. PubMed ID: 33007554
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects.
Shen W; Ren X; Zhu J; Xu Y; Lin J; Li Y; Zhao F; Zheng H; Li R; Cui X; Zhang X; Lu X; Zheng Z
Eur J Pharmacol; 2016 Nov; 791():205-212. PubMed ID: 27597161
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors.
Wang J; Wang X; Li H; Ji D; Li Y; Xu Y; Zhu Q
Bioorg Med Chem Lett; 2016 Aug; 26(16):4127-32. PubMed ID: 27353531
[TBL] [Abstract][Full Text] [Related]
37. Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study.
Galati S; Sainas S; Giorgis M; Boschi D; Lolli ML; Ortore G; Poli G; Tuccinardi T
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744791
[TBL] [Abstract][Full Text] [Related]
38. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: Synthesis, pharmacological and toxicological evaluation.
Dimitrijević MG; Roschger C; Lang K; Zierer A; Paunović MG; Obradović AD; Matić MM; Pocrnić M; Galić N; Ćirić A; Joksović MD
Bioorg Chem; 2024 Jun; 147():107359. PubMed ID: 38613925
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional comparison of agents interfering with dihydroorotate, succinate and NADH oxidation of rat liver mitochondria.
Jöckel J; Wendt B; Löffler M
Biochem Pharmacol; 1998 Oct; 56(8):1053-60. PubMed ID: 9776318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
